Medapp

Medapp CapEx/D&A

The CapEx to Depreciation Ratio of Medapp (MDA.WA) as of Nov 20, 2026 is 1.02.

CapEx/D&A

1.02

Last updated:

CapEx to Depreciation Ratio of Medapp is 2024 1.02 . CapEx to Depreciation Ratio of Medapp was 2023 0.00 . It decreases by % higher compared to the previous year.

The Medapp CapEx/D&A history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

CapEx/D&A
Date
CapEx/D&A
Jan 1, 2017
71.21 PLN
Jan 1, 2018
0.16 PLN
Jan 1, 2019
0.00 PLN
Jan 1, 2020
0.23 PLN
Jan 1, 2021
0.15 PLN
Jan 1, 2022
3.63 PLN
Jan 1, 2023
0.00 PLN
Jan 1, 2024
1.02 PLN
The Medapp CapEx/D&A history
YEARCapEx/D&AYoY
1.02—
0.00-100.00%
3.63+2,366.09%
0.15-34.86%
0.23—
0.00-100.00%
0.16-99.77%
71.21+3,175.93%
2.17—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Medapp Stock analysis

What does Medapp do? MedApp SA generates revenue through its mobile marketing solutions in the medical field, primarily via the Carna Life software application. Carna Life functions as a telemedicine platform enabling doctors and patients to communicate, with features including data upload and download for test results, offline data review, and graphical statistics. The company serves healthcare providers and patients seeking telemedicine services, focusing on the Polish market through its Krakow headquarters. Moonrock Enterprise SA controls MedApp SA, leveraging its software for medical communication solutions. The firm's revenue model centers on the Carna Life application, which provides telemedicine services by facilitating secure data exchange between doctors and patients. Patients use the app to upload test results, while doctors interpret them through the platform, supported by offline functionality and data visualization tools. This system targets medical professionals and patients in Poland, operating within the telemedicine sector without external partnerships or additional branded products. MedApp SA's business relies solely on the Carna Life telemedicine system, which offers both online and offline modes for data management. The application includes statistics, visualizations, and tables for interpreted medical data, serving as a communication channel between healthcare providers and patients. Controlled by Moonrock Enterprise SA, the company monetizes its software through direct sales to medical institutions and patient users in the Polish healthcare market. Medapp is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Medapp stock

CapEx to Depreciation Ratio of Medapp is 1.02 in 2024.

On Eulerpool you can find the complete historical development of CapEx to Depreciation Ratio Medapp since 2006 – with annual values, charts, and detailed analysis.

The CapEx/D&A ratio compares investment spending to asset depreciation. Ratios above 1.0x indicate the company is growing its asset base, below 1.0x suggests underinvestment.

A 'good' varies by industry and company stage. On Eulerpool, you can compare CapEx to Depreciation Ratio's Medapp with sector peers and the industry average to assess whether it is attractive.

To evaluate CapEx to Depreciation Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for CapEx to Depreciation Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Medapp

All Key Metrics — Medapp